醛固酮受体拮抗剂在慢性肾脏疾病中的应用

被引：6

作者：

何平

李德天

机构：

[1] 沈阳中国医科大学附属盛京医院肾内科

来源：

国际泌尿系统杂志 | 2006年 / 06期

关键词：

肾疾病; 慢性病; 受体,醛固酮;

D O I：

暂无

中图分类号：

R692 [肾疾病];

学科分类号：

100221 [泌尿外科学];

摘要：

本文主要综述醛固酮在肾脏疾病的发展和恶化中起的重要作用,独立于肾素和血管紧张素,并且讨论醛固酮受体拮抗剂的治疗意义。

引用

页码：823 / 826

页数：4

共 6 条

[1]

Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients [J].

Gross, E ;

Rothstein, M ;

Dombek, S ;

Juknis, HI .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :94-101

[2]

Antagonists of aldosterone and proteinuria in patients with CKD: An uncontrolled pilot study [J].

Bianchi, S ;

Bigazzi, R ;

Campese, VM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (01) :45-51

[3]

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype [J].

Cicoira, M ;

Zanolla, L ;

Rossi, A ;

Golia, G ;

Franceschini, L ;

Cabrini, G ;

Bonizzato, A ;

Graziani, M ;

Anker, SD ;

Coats, AJS ;

Zardini, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (07) :1808-1812

[4]

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.[J].Allan D. Struthers.Journal of Cardiac Failure.1996, 1

[5]

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats..Fujisawa G; Okada K; Muto S; et al;.Kidney Int.2004, 04

[6]

CYP11B2 expression in HSCs and its effect on hepatic fibrogenesis [J].

Li, X ;

Meng, Y ;

Yang, XS ;

Wu, PS ;

Li, SM ;

Lai, WY .

WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (06) :885-887

← 1 →